USPTO 2015–2025 USPTO PatentsView US Corporation

ImmunityBio, Inc.

USPTO PatentsView assignee record - 47 granted patents across 14 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Immunitybio ranks #7,019 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 14 technology areas.

#7,019
of 49,997 US assignees by volume
Top 6%
by Innovation Score (57.0/100)
17.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R7019 · US Corporation #7,019 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 47 grants
  • UPPER-Q #7,019/49,997
  • PHOTO-FINISH Indiana Mills &…
  • CPC-FOCUS A61K · 14 areas
  • INNOV-PAR 57.0/100
  • CLAIMS-RICH 17.3 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Indiana Mills & Manufacturing, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Immunitybio’s 57.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Immunitybio

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Immunitybio's Innovation Score is 57.0/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Immunitybio?

Each dot is one of Immunitybio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Immunitybio’s own 17.3 claims/patent is ABOVE the 15.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Immunitybio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 46.947.047.04747.047.047.1 051015202530 Granted patents (volume) Avg claims / patent Indiana Mills & Manufacturing, Inc. - 47, 18.85Indiana Mills & M…Inside Secure - 47, 18.36Inside SecureIntelligent Designs 2000 Corp. - 47, 3.96Intelligent Desig…Iteris, Inc. - 47, 25.06IterisInnovative Cellular Therapeutics Holdings, Ltd. - 47, 15.72Innovative Cellul…JMS Co., Ltd. - 47, 10.72JMSKennedy Valve Company - 47, 16.11Kennedy ValveKirchhoff Automotive Deutschland GmbH - 47, 15.49Kirchhoff Automot…ImmunityBio, Inc. - 47, 17.34Immunitybio
Immunitybio vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Immunitybio's grants concentrate

ImmunityBio, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 74.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (15 grants) versus a trough of 5 in 2023. By volume, Immunitybio sits between Indiana Mills & Manufacturing, Inc. and Kirchhoff Automotive Deutschland GmbH.

Immunitybio's three-year grant acceleration

ImmunityBio, Inc. shows 27 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at ImmunityBio's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows ImmunityBio holds 47 patents at rank #7,024, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near ImmunityBio

By rank, the assignees closest to #7,024 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in ImmunityBio's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ImmunityBio, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), ImmunityBio ranks #627 of 7,163 assignees by patent count in that subclass.

Immunitybio's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20212022202320242025 14
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
ImmunityBio, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 6 12.8%
2022 7 14.9%
2023 5 10.6%
2024 15 31.9%
2025partial year 14 29.8%

Which technologies does ImmunityBio, Inc. patent most?

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

ImmunityBio, Inc.'s patent record in context - here's where to go next.

  • ImmunityBio, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 74.5% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #7,019 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare ImmunityBio, Inc. against Indiana Mills & Manufacturing, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 57.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.